This paper described the outcomes of 119 patients who achieved CR after induction therapy, including 54 PTCL‐NOS, 35 AITL, and 30 ALK‐negative ALCL. This evidence concerns the gene ALK and mature T-cell and NK-cell non-Hodgkin lymphoma.